Clinical Research Directory
Browse clinical research sites, groups, and studies.
Combined Antibody Screening for Celiac and Diabetes Evaluation
Sponsor: Pacific Northwest Research Institute
Summary
The CASCADE Study (Combined Antibody Screening for Celiac and Diabetes Evaluation) is an observational study whose primary goal is to show that population-based screening for advanced prediction of type 1 diabetes (T1D) and celiac disease (CD) is feasible to prevent diabetic ketoacidosis (DKA), improve celiac disease diagnosis, and ultimately gain public health acceptance to facilitate future prevention. It has two arms, a Birth Cohort and a Kids (cross sectional) Cohort.
Key Details
Gender
All
Age Range
1 Day - 7 Years
Study Type
OBSERVATIONAL
Enrollment
64410
Start Date
2020-12
Completion Date
2026-06
Last Updated
2020-12-21
Healthy Volunteers
Yes
Conditions
Interventions
Combined Risk Score
Several factors will be analyzed to assign each subject combined risk score. This will assess the subject's risk of developing Type 1 Diabetes and/or Celiac Disease.
Locations (1)
Pacific Northwest Research Institute
Seattle, Washington, United States